Wai Conrad sold CLOV

September 15, 2026 · Form 4 insider transaction

Wai Conrad sold 300,000 shares of Clover Health Investments, Corp. at $4.72 per share, a transaction worth $1.42M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
300,000
Price
$4.72
Total value
$1.42M
InsiderWai Conrad
Role
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 15, 2026
Filing dateSeptember 16, 2026
Shares owned after1,170,056
OwnershipIndirect
10b5-1 planYes
AmendedNo

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.60 to $5.06, inclusive. The Reporting Person undertakes to provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.; Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.

View the original Form 4 on SEC EDGAR
Wai Conrad sold CLOV: September 15, 2026 | Insider Trading Screener